Daptomycin and Norepinephrine bitartrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Daptomycin (daptomycin) and Norepinephrine bitartrate (norepinephrine bitartrate). Common drug interactions include blood pressure fluctuation among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Daptomycin and Norepinephrine bitartrate. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Norepinephrine bitartrate?

Norepinephrine bitartrate has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,370 Norepinephrine bitartrate users. Check the latest studies of Norepinephrine bitartrate.



On Jun, 02, 2026

17 people who take Daptomycin and Norepinephrine bitartrate together, and have interactions are studied.

Daptomycin and Norepinephrine bitartrate drug interactions.

What are the common drug interactions of Daptomycin and Norepinephrine Bitartrate, by gender? *:

female:

  1. Blood pressure fluctuation
  2. Chills (felling of cold)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  6. Enterocolitis haemorrhagic (bleeding and inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  7. Hyperglycaemia (high blood sugar)
  8. Hypotension (abnormally low blood pressure)
  9. Lung infection
  10. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Cardiac failure congestive
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Cardiac output decreased
  4. Cardiogenic shock (inadequate circulation of blood)
  5. Cerebellar ischaemia (lack of blood supply to cerebeller)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Haematoma (collection of blood outside the blood vessels)
  10. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

What are the common drug interactions of Daptomycin and Norepinephrine Bitartrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Injury
  2. Multi-organ failure (multisystem organ failure)
  3. Nervousness
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal injury (kidney injury)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Depression
  10. Emotional distress

40-49:

  1. Blood pressure fluctuation
  2. Chills (felling of cold)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Enterocolitis haemorrhagic (bleeding and inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  6. Hypotension (abnormally low blood pressure)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Rectal haemorrhage (bleeding from anus)
  9. Septic shock (shock due to blood infection)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

  1. Hepatic failure (liver failure)
  2. Aortic thrombosis (formation of a blood clot inside aorta)
  3. Arrhythmia (irregular heartbeat)
  4. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  5. Cardiac failure congestive
  6. Cardiac output decreased
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Cerebellar ischaemia (lack of blood supply to cerebeller)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Anaemia (lack of blood)
  3. Hypotension (abnormally low blood pressure)
  4. Loss of consciousness
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  6. Nausea (feeling of having an urge to vomit)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Pneumonia
  9. Renal failure acute (rapid kidney dysfunction)
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 11.76%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 11.76%
  3. Sedation: 2 people, 11.76%
  4. T-Cell Lymphoma (a blood cell cancer): 1 person, 5.88%
  5. Retinopathy Proliferative (a condition in which very small blood vessels grow from the surface of the retina and damages retina): 1 person, 5.88%
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 5.88%
  7. Pain: 1 person, 5.88%
  8. Nausea (feeling of having an urge to vomit): 1 person, 5.88%
  9. Heparin-Induced Thrombocytopenia: 1 person, 5.88%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and Norepinephrine bitartrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Daptomycin and Norepinephrine bitartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Norepinephrine bitartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norepinephrine bitartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on daptomycin and norepinephrine bitartrate (the active ingredients of Daptomycin and Norepinephrine bitartrate, respectively), and Daptomycin and Norepinephrine bitartrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: